Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Ritonavir
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Lopinavir and Ritonavir Kaletra
®
Infections, Protease inhibitors, 05.03.01
RED
Nirmatrelvir 150mg with ritonavir 100mg tablets Paxlovid
®
(150 mg/100 mg film-coated tablets)
Infections, Antiviral drugs, 05.03
RED
Ombitasvir/ paritaprevir/ ritonavir Viekirax
®
(Tablets)
Infections, Chronic hepatitis C, 05.03.03.02
RED
Ritonavir
Infections, Protease inhibitors, 05.03.01
Amber SPA
Ticagrelor 60mg, 90mg Brilique
®
(Tablets )
Cardiovascular system, Antiplatelet drugs, 02.09
Amber SPA
Ticagrelor 90mg Brilique
®
(Orodispersible tablets)
Cardiovascular system, Antiplatelet drugs, 02.09
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Lopinavir
Lopinavir With Ritonavir
Anti-Infective, Viral Infection, HIV Infection, Antivirals Protease Inhibitors, HIV
Nirmatrelvir
Nirmatrelvir With Ritonavir
Anti-Infective, Viral Infection, Coronavirus, Antivirals Antivirals, Other
Ritonavir
Ritonavir
Anti-Infective, Viral Infection, HIV Infection, Antivirals Protease Inhibitors, HIV
Links found
Medicine Request Form - Nirmatrelvir/Ritonavir (Paxlovid)
MHRA DSU Nov 2023 Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions with ritonavir
MHRA DSU Oct 2018: Ritonavir-containing products: reports of interaction with levothyroxine leading to reduced thyroxine levels
NICE TA365: Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C
NICE TA365: Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C
NICE TA878: Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19